US House appropriators add Rx-to-OTC drug ingredient switches and oversight of homeopathic drugs to their list of concerns about the Food and Drug Administration’s work in a report accompanying the fiscal year 2021 spending bill for the agency.
The Appropriations Committee’s report provided with its passage of the Agriculture, Rural Development, FDA and Related Agencies FY2021 budget on 9 July also renewed a statement of concern about...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?